Skip to content
About CombiGene
Projects
The pain program COZY
The epilepsy project CG01
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Organization
Articles of association (SE)
Company description (SE)
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
About CombiGene
Projects
The pain program COZY
The epilepsy project CG01
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Organization
Articles of association (SE)
Company description (SE)
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
SV
Financial calendar
8 November, 2024
Interim report January-September 2024
14 February, 2025
Year-end report 2024
Financial reports
November 8, 2024
Interim report January – September 2024 for CombiGene AB (publ)
August 23, 2024
Interim report January – June 2024 for CombiGene AB (publ)
May 17, 2024
Interim report January – March 2024 for CombiGene AB (publ)
April 26, 2024
CombiGene AB (publ) publishes annual report for 2023
February 16, 2024
Year-end report January-December 2023 CombiGene AB (Publ)
November 10, 2023
Interim report January – September 2023 for CombiGene AB (publ)
Load more
We use cookies to ensure that we give you the best experience on our website. If you continue to use this website, we will assume that you accept it.
Ok
Privacy policy
